相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation
Weifeng Zhang et al.
BIOMATERIALS (2014)
Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation
Nani Wibowo et al.
VACCINE (2014)
Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo
Kenichi Niikura et al.
ACS NANO (2013)
Modular engineering of a microbially-produced viral capsomere vaccine for influenza
Nani Wibowo et al.
CHEMICAL ENGINEERING SCIENCE (2013)
Immunization with Apical Membrane Antigen 1 Confers Sterile Infection-Blocking Immunity against Plasmodium Sporozoite Challenge in a Rodent Model
Sophie Schussek et al.
INFECTION AND IMMUNITY (2013)
Vaccine delivery carriers: Insights and future perspectives
J. F. Correia-Pinto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Re-considering how particle size and other properties of antigen-adjuvant complexes impact on the immune responses
Shiyu Yan et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2013)
M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A
Lorena Itati Ibanez et al.
PLOS ONE (2013)
A Single-Dose PLGA Encapsulated Protective Antigen Domain 4 Nanoformulation Protects Mice against Bacillus anthracis Spore Challenge
Manish Manish et al.
PLOS ONE (2013)
Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)
Tania Rivera-Hernandez et al.
VACCINE (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
High-yield and scalable cell-free assembly of virus-like particles by dilution
Mervyn W. O. Liew et al.
BIOCHEMICAL ENGINEERING JOURNAL (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanoparticle Hydrophobicity Dictates Immune Response
Daniel F. Moyano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
James J. Moon et al.
PLOS ONE (2012)
Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T Cells
Helen Vallhov et al.
SMALL (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice
Chang Zhou et al.
VACCINE (2012)
Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens
Antu K. Dey et al.
EXPERT REVIEW OF VACCINES (2011)
Aerosolized PLA and PLGA Nanoparticles Enhance Humoral, Mucosal and Cytokine Responses to Hepatitis B Vaccine
Chandan Thomas et al.
MOLECULAR PHARMACEUTICS (2011)
Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications
Chih-Hang Chu et al.
NANOTECHNOLOGY (2011)
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Anton P. J. Middelberg et al.
VACCINE (2011)
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles
Sharmila Pejawar-Gaddy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
Moses O. Oyewumi et al.
EXPERT REVIEW OF VACCINES (2010)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Novel Multiparametric Approach to Elucidate the Surface Amine-Silanization Reaction Profile on Fluorescent Silica Nanoparticles
Shibsekhar Roy et al.
LANGMUIR (2010)
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
Gayathri Bommakanti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs
Tilo Senger et al.
VACCINE (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Nanocarriers' entry into the cell: relevance to drug delivery
Herve Hillaireau et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity
Lysann Schaedlich et al.
JOURNAL OF VIROLOGY (2009)
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Julie A. Champion et al.
PHARMACEUTICAL RESEARCH (2009)
Structure, attachment and entry of polyoma- and papillomaviruses
Martin Sapp et al.
VIROLOGY (2009)
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
Yoshihiko Murata et al.
VIROLOGY JOURNAL (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Coming of age of virus-like particle vaccines
Gary T. Jennings et al.
BIOLOGICAL CHEMISTRY (2008)
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery
B. Sayin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Nanoparticles and microparticles as vaccine-delivery systems
Manmohan Singh et al.
EXPERT REVIEW OF VACCINES (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
J Singh et al.
METHODS (2006)
Pathogen recognition and development of particulate vaccines: Does size matter?
Sue D. Xiang et al.
METHODS (2006)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
C Foged et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice
T Fifis et al.
VACCINE (2004)
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge
AK Kohli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
PEGylated nanoparticles for biological and pharmaceutical applications
H Otsuka et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres
M Diwan et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants
RS Raghuvanshi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
分享论文
